Technetium-99m-MIBI and thallium-201 scintigraphy of primary lung cancer

Journal of Nuclear Medicine

Volumn 38, Issue 9, 1997, Pages 1358-1361

  Nishiyama, Yoshihiro ^a   Kawasaki, Yukiko ^a   Yamamoto, Yuka ^a   Fukunaga, Koutarou ^a   Satoh, Katashi ^a   Takashima, Hitoshi ^a   Ohkawa, Motoomi ^a   Tanabe, Masatada ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Dual isotope imaging; Lung cancer; Technetium 99m MIBI; Thallium 201 chloride

Indexed keywords

FLUORODEOXYGLUCOSE F 18; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM CHLORIDE TL 201;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG SCINTISCANNING; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MALE; PRIORITY JOURNAL; RADIOISOTOPE DISTRIBUTION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0030884689     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and single photon emission computed tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med 1992;19:86-95.
2. Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single-photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
3. Yuka Y, Kusuhara T, Kumazawa Y, et al. The effect of scattering in simultaneous acquisitions of technetium-99m and thallium-201: a fundamental study through phantom experiments. Radioisotopes 1996;45:369-374.
4. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of technetium-99m-hexakis 2-methoxy isobutyl isonitrile in benign and malignant lesions in the lungs. Clin Nucl Med 1989;14:333-340.
5. Actolun C, Bayhan H, Kir M. Clinical experience with technetium-99m-MIBI imaging in patients with malignant tumors: preliminary results and comparison with thallium-201. Clin Nucl Med 1992;17:171-176.
6. Shirakawa T, Mori Y, Moriya E, et al. Uptake of technetium-99m-hexakis 2-methoxy isobutyl isonitrile in lung or mediastinal lesions by SPECT. Nippon Acta Radiol 1995;55:587-592.
7. Kao CH, Wang SJ, Lin WY, Hsu CY, Liao SQ, Yeh SH. Differentiation of single solid lesions in the lungs by means of single photon emission tomography with technetium-99m-methoxyisobutylisonitrile. Eur J Nucl Med 1993;20:249-254.
8. Desai SP, Yuille DL. Visualization of a recurrent carcinoid tumor and an occult distant metastasis by technetium-99m-sestamibi. J Nucl Med 1993;34:1748-1751.
9. Strouse PJ, Wang DC. Incidental detection of bronchogenic carcinoma during technetium-99m-sestamibi cardiac imaging. Clin Nucl Med 1993;18:448-449.
10. Cancer B, Kitapci M, Erbengi G, Gogus T, Bekdik C. Increased accumulation of technetium-99m-MIBI in undifferentiated mesenchymal tumor and its metastatic lung lesions. Clin Nucl Med 1992;17:144-145.
11. Togawa T, Suzuki A, Kato K, et al. Relation between thallium-201 to gallium-67 uptake ratio and histological type in primary lung cancer. Eur J Cancer Clin Oncol 1985;21:925-930.
12. Namba P, Narabayashi I, Matsui R, et al. Evaluation of thallium-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors. Ann Nucl Med 1995;9:65-74.
13. Kishida T. Mechanism of thallium-201 accumulation to thyroid gland: clinical usefulness of dynamic study in thallium-201 chloride scintigraphy for differential diagnosis of thyroid nodules. Kagu lgaku 1987;24:991-1004.
14. Ito Y, Muranaka A, Harada T, Matsudo A, Yokobayashi T, Terashima H. Experimental study on tumor affinity of thallium-201-chloride. Eur J Nucl Med 1978;3:81-86.
15. Sehweil AM, McKillop JH, Milroy R, Wilson R, Abdel-Dayem HM, Omar YT. Mechanism of thallium-201 uptake in tumors. Eur J Nucl Med 1989;15:376-379.
16. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium (I) in cultured mouse fibroblasts. J Nucl Med 1990;31:1646-1653.
17. Ballinger JR, Hua HA, Berry BW, Firby P, Boxen I. Technetium-99m-sestamibi as an agent for imaging P-glycoprotein-mediated multidrug resistance: in vitro and in vivo studies in a rat breast tumor cell line and its doxorubicin-resistant variant. Nucl Med Commun 1995;16:253-257.
18. Dimitrakopoulou-Strauss A, Strauss LG, Goldschmidt H, Lorenz WJ, Maier-Borst W, Van Kaick G. Evaluation of tumor metabolism and multidrug resistance in patients with treated malignant lymphomas. Eur J Nucl Med 1995;22:434-442.
19. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994;35:510-515.
20. Komori T, Matsui R, Adachi I, Shimizu T, Sueyoshi K, Narabayashi I. In vitro uptake and release of thallium-201 and technetium-99m-MIBI in Hela cell. Kaku Igaku 1995;32:651-658.
21. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with PET: a prospective study. J Nucl Med 1990;31:1927-1933.